Form 4: Pacific Biosciences Director Shapiro Acquires Shares and Options

Director Lucy Shapiro acquired shares and options in Pacific Biosciences of California, Inc. on June 18, 2024.

Summary

• On June 18, 2024, Lucy Shapiro, a director of Pacific Biosciences of California, Inc., acquired 22,821 shares of common stock represented by Restricted Stock Units (RSUs).
• These RSUs will vest on the one-year anniversary of the grant date or the date of the next annual meeting, provided Shapiro remains a director.
• Shapiro also acquired options to purchase 32,179 shares of common stock at an exercise price of $1.65.
• These options will vest monthly over one year, contingent on Shapiro's continued service as a director.
• Following these transactions, Shapiro directly owns 22,821 shares and options for 32,179 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the filing itself is a standard disclosure, insider purchases can be interpreted as a sign of confidence in the company's prospects.

Positives

• A director's acquisition of shares and options can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedules for the RSUs and stock options are contingent on the director's continued service, aligning her interests with the company's long-term performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company insiders, which can be informative for investors.

Stakeholder Impact

• The acquisition of shares and options by a director could positively influence shareholder sentiment.

Key Dates